Search the GHTC website
October 17, 2022

Developing new antimalarial drugs for malaria-free pregnancies

The 2022 World Health Summit, taking place from October 16 to 18, brings together scientific, political, private, and civil society sectors to discuss the achievement of health for all. It is an opportunity to draw attention to the fact that pregnant women are underserved by currently available antimalarial therapies. Medicines for Malaria Venture (MMV), through its Malaria in mothers and babies (MiMBa) strategy, is working with partners to close critical gaps in the availability of well-tolerated malaria prevention and treatment methods for pregnant women to achieve true health for all. 
September 20, 2022

World Contraception Day 2022 quiz: Name that contraceptive method

How much do you know about the history of contraceptive innovation? Take GHTC's World Contraception Day quiz to test your knowledge.

March 8, 2022

A call to scale up preventive malaria treatment for pregnant women in sub-Saharan Africa

On International Women's Day, Medicines for Malaria Venture calls for sustained action to address biases, discrimination, and inequities that affect women and girls, including their access to malaria prevention and treatment. 

October 7, 2021

Increasing access to malaria interventions for adolescent girls is an important step toward malaria elimination

While gains have been made in global malaria control, little progress has been made in reducing malaria-related deaths among adolescents. The protection of populations such as adolescents, and particularly girls, has been largely overlooked—despite malaria being one of the major causes of death and ill health in these populations.